Diagnostic criteria in clinical trials

Neurology

Volumn 47, Issue 4 SUPPL., 1996, Pages

  Brooke, Michael H ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE; FREE RADICAL; PREDNISONE; SCAVENGER;

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CLINICAL TRIAL; DUCHENNE MUSCULAR DYSTROPHY; ELECTROMYOGRAPHY; GUILLAIN BARRE SYNDROME; HUMAN; PRIORITY JOURNAL; REFLEX; SPASTICITY; SPINAL MUSCULAR ATROPHY;

EID: 0029804801     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.47.4_suppl_2.67s     Document Type: Article

References (5)

1. Munsat TL, ed. Quantification of Neurological Deficit. Boston: Butterworths, 1989.
2. Meynert CL. Clinical Trials. Design Conduct and Analysis. Oxford: Oxford University Press, 1986.
3. Parkinson Study Group. DATATOP, a multicenter controlled clinical trial in early Parkinson's disease. Arch Neurol 1989; 46:1052-1060.
4. Brooke MH, Griggs RC, Mendell JR, Fenichel GM, Shumate JB, Pellegrino RH. Clinical trial in Duchenne dystrophy. 1. The design of the protocol. Muscle Nerve 1981;4:186-197.
5. Brooks BR. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial "Clinical limits of amyotrophic lateral sclerosis" workshop contributors. J Neurol Sci 1994;124(suppl):96-107.